Navigation Links
Clarient Reports 2009 Third Quarter; Nine Month Results
Date:11/3/2009

Management believes that using Adjusted EBITDA as a metric can enhance an overall understanding of the Company's expected financial performance from ongoing operations, and Adjusted EBITDA is used by management for that purpose. We believe that Adjusted EBITDA is frequently used by analysts, investors and other interested parties in evaluating companies such as ours and that it provides a useful measure of our financial performance since its use eliminates the effects of period to period changes in costs associated with impairment of assets related to capital investments, interest on our debt, capital lease obligations and non-cash stock based compensation charges. In addition, under our credit facilities with Gemino Healthcare Finance LLC, we are required to maintain minimum levels of Adjusted EBITDA.

There are limitations inherent in non-GAAP financial measures such as Adjusted EBITDA in that they exclude a variety of charges and credits that are required to be included in a GAAP presentation, and do not therefore present the full measure of the Company's recorded costs against its revenue. Management compensates for these limitations in non-GAAP measures by also evaluating our performance based on traditional GAAP financial measures. Accordingly, in analyzing our future financial performance, investors should consider these non-GAAP results together with GAAP results, rather than as an alternative to GAAP basis financial measures.

    Contact:
    Matt Clawson
    949.474.4300
    matt@allencaron.com

TABLES FOLLOW


                                Clarient, Inc.
               Condensed Consolidated Statements of Operations
              (in thousands, except share and per share amounts)
                                 (Unaudited)

                                   Three Months Ended      Nine Months Ended
           
'/>"/>
SOURCE  Clarient, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 

Related biology technology :

1. Clarient to Present at Noble Financials 5th Annual Equity Conference on Tuesday, June 9th
2. Clarient Completes Second Tranche of Private Placement of Convertible Preferred Stock With Oak Investment Partners
3. Clarient Granted Exclusive License to Commercialize Breast Cancer Biomarker by Indiana University Research and Technology Corporation
4. Clarient Reports Strong Revenue Increase for Fourth Quarter and Full-Year 2008
5. [video] Ronald Andrews, CEO of Clarient, Inc. Discusses Agreement With University of Pennsylvania School of Medicine on WallSt.nets 3-Minute Press Show
6. Clarient Names Raymond J. Land Senior Vice President and Chief Financial Officer
7. Jim Agnello to Resign as Clarient Chief Financial Officer
8. Clarient Announces Fourth Quarter and Year-End 2007 Financial Results
9. CombiMatrix and Clarient Collaborate to Market, Sell Novel Genomics-Based Test for Chronic Lymphotic Leukemia (CLL)
10. Clarient to Commercialize Novel Breast Cancer Profile
11. Clarient CEO Ron Andrews to Participate in OneMedPlace Emerging Healthcare Technologies Finance Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... Mechanicsburg, Pa (PRWEB) May 20, 2013 ... controller with ramp/soak capabilities. The 5R6-900 benchtop controller ... enclosure, the device can be plugged into the wall ... own power supply. This distinctive detail makes the device ... , The laboratory temperature controller can also be ...
(Date:5/20/2013)... 20, 2013  (PSHR) Pacific Shore Holdings, Inc. ... across a broad range of product categories lines, ... relations firm, BlueWater Advisory Group, to provide strategic ... process, and to direct the company,s outreach and ... Matthew Mills , Pacific Shore ...
(Date:5/20/2013)... With bed bugs' presence come problems in ... bugs need to be eliminated, one must make sure that ... health. And so to help bed bug sufferers get that ... of bed bugs without using harmful pesticides. In it, ... called Bed Bug Bully. , According to My Cleaning Products, ...
(Date:5/20/2013)... 2013   Flexion Therapeutics , Inc. today announced ... to its management team as chief financial officer. ... management experience with biotechnology and medical device companies. ... financial officer for Novavax (NASDAQ: NVAX ) ... $250 million through a combination of investment funding and ...
Breaking Biology Technology:New Laboratory Temperature Controller by Oven Industries 2Pacific Shore Holdings Retains Investor Relations Firm 2New Non Pesticide Discovery on How to Get Rid of Bed Bugs Tipped by My Cleaning Products 2Flexion Therapeutics Names Frederick Driscoll Chief Financial Officer 2
... simple peptides can organize into bi-layer membranes. The ... chemical inventory and the organizational scaffolding essential to life. ... kind of membranes needed to create long-range order," says ... paper recently published by the German Chemical Society,s ...
... /PRNewswire-FirstCall/ - Oncothyreon Inc. (NASDAQ: ONTY ) (the "Company") today ... per basic and diluted share for the quarter ended March ... or $0.13 per basic and diluted share for the ... result of a decrease in fair value of warrant liability of ...
... LEIDEN, The Netherlands , May 6, ... NASDAQ: CRXL ; Swiss,Exchange: CRX) today announced the ... to supply its paediatric vaccine Quinvaxem(R) to the developing,world. ... the Millennium Development Goals set by the United Nations, ...
Cached Biology Technology:Peptides may hold 'missing link' to life 2Peptides may hold 'missing link' to life 3Oncothyreon reports first quarter 2010 financial results 2Oncothyreon reports first quarter 2010 financial results 3Oncothyreon reports first quarter 2010 financial results 4Oncothyreon reports first quarter 2010 financial results 5Crucell Announces New Award of $110 Million for Paediatric Vaccine Quinvaxem(R) by UNICEF to Support Vaccination Programs in the Developing World 2Crucell Announces New Award of $110 Million for Paediatric Vaccine Quinvaxem(R) by UNICEF to Support Vaccination Programs in the Developing World 3Crucell Announces New Award of $110 Million for Paediatric Vaccine Quinvaxem(R) by UNICEF to Support Vaccination Programs in the Developing World 4
(Date:5/21/2013)... to a whale entangled in fishing gear, scientists showed ... whale,s diving and swimming behavior. The monitoring revealed how ... depletes their energy as they drag gear for months ... , The scientists in this entanglement response suction-cupped a ... North Atlantic right whale called Eg 3911. The Dtag, ...
(Date:5/21/2013)... being considered in the management of natural resources, ... can help them recognize and respond to the ... lives. , Place-Based Conservation: Perspectives from the ... Pacific Northwest Research Station,s Linda Kruger, can help ... book is published by Springer Verlag and is ...
(Date:5/21/2013)... RICHLAND, Wash. A new analysis shows that the ... growth of enough algae to produce up to 25 ... United States, one-twelfth of the country,s yearly needs. , ... water resources that would be needed to grow significant ... The results were published in the May 7 issue ...
Breaking Biology News(10 mins):Study reveals how fishing gear can cause slow death of whales 2Study reveals how fishing gear can cause slow death of whales 3Going green: Nation equipped to grow serious amounts of pond scum for fuel 2Going green: Nation equipped to grow serious amounts of pond scum for fuel 3Going green: Nation equipped to grow serious amounts of pond scum for fuel 4
... central to fully understanding and modeling the pelagic (open ocean) ... numerical study conducted by the University of Miami (UM) incorporates ... creating a powerful tool that spells out how larvae use ... after being out on the open ocean. The new ...
... ,Brain freeze, is a nearly universal experiencealmost everyone has felt ... cream or slurp of ice-cold soda on the upper palate. ... phenomenon. Since migraine sufferers are more likely to experience brain ... freeze may share a common mechanism with other types of ...
... (New York, NY, April 22, 2012) Researchers at ... pathway that controls the retention and release of the ... normal and abnormal neurologic development and could eventually lead ... findings, from a collaborative effort of the laboratories of ...
Cached Biology News:Fish larvae find the reef by orienting: The earlier the better 2Fish larvae find the reef by orienting: The earlier the better 3Changes in brain's blood flow could cause 'brain freeze' 2Changes in brain's blood flow could cause 'brain freeze' 3'Housekeeping' mechanism for brain stem cells discovered 2'Housekeeping' mechanism for brain stem cells discovered 3
... bioassays for interferons are cytopathic effect inhibition assays, ... Sample types include; tissue culture supernatents; serum from ... assays, one unit is defined as the quantity ... cytopathic effect of viral infection by 50%. ...
HyPro 20 system for slide hybridization. 20 slide capacity. Active vibration system, slide rack and humidity chamber. Ideal for microarray and in situ hybridization....
... bioassays for interferons are cytopathic effect inhibition assays, ... Sample types include; tissue culture supernatents; serum from ... assays, one unit is defined as the quantity ... cytopathic effect of viral infection by 50%. ...
Request Info...
Biology Products: